APA   Click to copy
D'Angelo, A., Chapman, R., Sirico, M., Sobhani, N., Catalano, M., Mini, E., & Roviello, G. (2022). An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next. Cancer Chemotherapy and Pharmacology, 90(3), 191–205. https://doi.org/10.1007/s00280-022-04459-7

Chicago/Turabian   Click to copy
D'Angelo, Alberto, Robert Chapman, Marianna Sirico, Navid Sobhani, Martina Catalano, Enrico Mini, and Giandomenico Roviello. “An Update on Antibody-Drug Conjugates in Urothelial Carcinoma: State of the Art Strategies and What Comes Next.” Cancer Chemotherapy and Pharmacology 90, no. 3 (2022): 191–205.

MLA   Click to copy
D'Angelo, Alberto, et al. “An Update on Antibody-Drug Conjugates in Urothelial Carcinoma: State of the Art Strategies and What Comes Next.” Cancer Chemotherapy and Pharmacology, vol. 90, no. 3, 2022, pp. 191–205, doi:10.1007/s00280-022-04459-7.

@article{alberto2022a,
  title = {An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next},
  year = {2022},
  issue = {3},
  journal = {Cancer Chemotherapy and Pharmacology},
  pages = {191-205},
  volume = {90},
  doi = {10.1007/s00280-022-04459-7},
  author = {D'Angelo, Alberto and Chapman, Robert and Sirico, Marianna and Sobhani, Navid and Catalano, Martina and Mini, Enrico and Roviello, Giandomenico}
}